Burning Rock Biotech (BNR) Receivables - Net (2020 - 2025)
Historic Receivables - Net for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $25.8 million.
- Burning Rock Biotech's Receivables - Net rose 884.72% to $25.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.8 million, marking a year-over-year increase of 884.72%. This contributed to the annual value of $20.8 million for FY2024, which is 1655.47% up from last year.
- Burning Rock Biotech's Receivables - Net amounted to $25.8 million in Q3 2025, which was up 884.72% from $26.5 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Receivables - Net ranged from a high of $26.5 million in Q2 2025 and a low of -$2.2 million during Q2 2022
- In the last 5 years, Burning Rock Biotech's Receivables - Net had a median value of $19.3 million in 2023 and averaged $18.1 million.
- Per our database at Business Quant, Burning Rock Biotech's Receivables - Net plummeted by 11778.9% in 2022 and then surged by 101802.14% in 2023.
- Burning Rock Biotech's Receivables - Net (Quarter) stood at $20.6 million in 2021, then rose by 7.52% to $22.2 million in 2022, then decreased by 19.38% to $17.9 million in 2023, then rose by 16.55% to $20.8 million in 2024, then increased by 24.0% to $25.8 million in 2025.
- Its Receivables - Net stands at $25.8 million for Q3 2025, versus $26.5 million for Q2 2025 and $22.0 million for Q1 2025.